Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sigma Healthcare Ltd ( (AU:SIG) ) has provided an announcement.
Sigma Healthcare reported robust sales growth across Chemist Warehouse branded stores, with Australian like-for-like sales up 14.4% and international like-for-like sales up 11.8%, underpinned by sustained demand and a lasting uplift from GLP1-related sales. Management said the strong performance, including higher basket sizes from GLP1 customers, underlines the defensive nature of its model and supports continued execution of its growth strategy.
The company also unveiled a measured entry into the UK market through a joint venture with GreenLight Healthcare, initially rebranding up to five London-area pharmacies as Chemist Warehouse stores. In New Zealand, Sigma committed about A$40m to a long-term leased, highly specified distribution centre near Auckland to support an expanded store network, targeting more than 100 Chemist Warehouse outlets over time and reinforcing supply chain resilience amid global disruptions.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.60 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare is an Australian pharmaceutical wholesaler and retailer that operates the Chemist Warehouse network and related pharmacy brands. The company focuses on pharmacy distribution, retail pharmacy services and international expansion, with growing footprints in New Zealand, Ireland, the Middle East, China online and now the United Kingdom.
YTD Price Performance: -3.70%
Average Trading Volume: 17,291,952
Technical Sentiment Signal: Buy
Current Market Cap: A$32.27B
For a thorough assessment of SIG stock, go to TipRanks’ Stock Analysis page.